No takes yet. Share an insight, caveat, or question.
This review explores the pharmacology and structure-activity relationships of psychedelics for treating neuropsychiatric disorders, suggesting new therapeutic approaches.
Bhat et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: